News Daily News OPTIMAX: First-in-Human Results Promising for Biocompatible Cobalt-Chromium Stent Yael L. Maxwell September 14, 2015
News Conference News ESC 2015 EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS Caitlin E. Cox September 02, 2015
News Conference News ESC 2015 ABSORB Trials Pit BRS Against Second-Generation DES Caitlin E. Cox September 02, 2015
Presentation ESC 2015 12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions Presenter: Takeshi Kimura September 01, 2015
News Industry News Abbott Announces Positive Results Of Its Naturally Dissolving Stent From Absorb Japan Study September 01, 2015
News Conference News ESC 2015 OPTIDUAL: No Clear Need to Lengthen DAPT to 4 Years After DES Caitlin E. Cox August 31, 2015
News Daily News Registry Study Suggests Absorb BVS Matches DES in Diabetic All-Comers August 27, 2015
News Daily News No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES Yael L. Maxwell August 26, 2015
News Industry News Boston Scientific Announces FDA Approval of Innova™ Vascular Self-Expanding Stent System August 19, 2015
News Industry News Proteon Therapeutics Announces Top-Line Results From Phase 1 Study of Investigational Drug Vonapanitase in Patients With Symptomatic Peripheral Artery Disease August 14, 2015
News Industry News Vascular Solutions Expands Launch of PolarCath(TM) System With 0.035” Catheters August 03, 2015
News Industry News Tryton Medical Announces Completion of Enrollment in the EXTENDED ACCESS Registry for its Tryton Side Branch Stent August 03, 2015
News Daily News Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes Yael L. Maxwell July 29, 2015
News Industry News Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology July 29, 2015
News Industry News First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate) July 29, 2015
News Daily News BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries Yael L. Maxwell July 29, 2015